-
Samsung expects 780% quarterly operating profit jump on AI boom
-
As species decline, green turtles offer glimmer of hope
-
Guardians survive with 9-3 win over White Sox
-
Brothers Scott and Beauden Barrett named to start for All Blacks
-
Saudi Arabia says 3 dead at airports after Houthis claim attacks
-
EU trade chief seeks to dial down China tensions
-
Stocks slide as oil sees volatile trading day over Iran war fears
-
'Never again Bolsonaro': thousands march ahead of Brazil election runoff
-
Microsoft pushes AI vision with new, expensive Surface laptop
-
After botched execution, US woman was nearly taken off life support before revival
-
Five children among 28 killed in Russian strikes on Ukraine
-
Searing AIDS drama 'Elsinore' opens London film festival
-
Odell Beckham Jr signs with Minnesota Vikings
-
Evicted pensioner who sparked Spain housing protests dies: tenant union
-
Saudi Arabia says three dead at airports after Houthis claim attacks
-
Golf star Rahm quitting LIV tour over 'unacceptable' terms
-
Trump plans to turn Florida golf course into presidential retreat
-
Thousands march fearing return of a Bolsonaro presidency in Brazil
-
WHO says cannot conduct full risk assessment on Russia plague reports
-
French PM denies police ordered to confront student protesters
-
After botched execution, US woman is awake and shackled to bed
-
Rubio touts US power, calls on Europe to emerge from 'slumber'
-
New Zealand fly-half Mo'unga ruled out of Australia Tests
-
Trump says 'we don't think' Russian plague is bio-weapon
-
Protests in major Turkish city after mayor defects to Erdogan party
-
Five children among 26 killed in Ukraine after Russian strikes
-
Climate change strips island's title of largest penguin colony: study
-
Man City should 'accept' punishment for rule breaches, says Lineker
-
Rubio says West must choose between national power or decline
-
US woman who survived botched execution is awake and speaking
-
Russia's plague scare: What we know
-
From 1800s to modern pharma: a Nobel-winning chemistry quest
-
French luxury giant to fund redevelopment of two Paris streets: city hall
-
Southampton boss Eckert given suspended ban over 'Spygate'
-
Trump wants to turn Florida golf course into presidential retreat
-
Russia warns of 'false' information as second plague case reported
-
Mayor of Turkish opposition stronghold defects to Erdogan party
-
IEA ready to release more oil reserves if necessary
-
Children among heavy casualties in Ukraine after Russian strikes
-
HSBC 'consults' over UK unit job cuts amid AI adoption
-
Court orders German ex-spy chief kept in jail after spying, treason arrest
-
UK court quashes five ex-traders' Libor rate rigging convictions
-
Guinea caps bottled water prices after sachets banned
-
XM Receives “Global Customer Experience Leader Award 2026” at the TrustFinance Performance Awards
-
Spared, married, hanged: the last weeks of Iranian protester Alireza Sepahi
-
Stocks slide as oil climbs on Mideast flareup
-
Nobel physics winner's pride at pioneering AI role
-
Heavy casualties in Ukraine after Russian strikes
-
IMF preparing El Nino assistance, concerned about AI bubble burst: chief to AFP
-
French wine harvest set to hit historic low
Biden calls for lower prices of Ozempic, similar drugs
US President Joe Biden on Tuesday called on pharmaceutical giants Novo Nordisk and Eli Lilly to lower prices for diabetes and weight loss drugs such as Ozempic, saying firms must stop "ripping off the American people."
In an article written with Senator Bernie Sanders, Biden said US patients pay several times more than in Canada, Germany and Denmark for Nordisk's diabetes drugs Ozempic and Wegovy, which can also be used for weight loss.
One-month supply of Ozempic in the United States last year was $936, compared to $169 in Canada and $103 in Germany, according to one study.
Eli Lilly was also charging "unconscionably high prices" for Mounjaro, a drug similar to Ozempic.
"Why should people in Burlington, Vermont, pay so much more than people in Copenhagen or Berlin for the same drug?" wrote Biden and Sanders, who chairs the Senate healthcare committee.
Such "price gouging" makes the drugs unaffordable to millions of Americans, they said.
"If the prices of these drugs are not substantially reduced, they have the potential to bankrupt the American health care system," Biden and Sanders wrote. "We will not allow that to happen."
Nordisk and Lilly did not immediately respond to an AFP request for comment.
High prices for prescription drugs have been a long-standing problem for American patients, and Democrat Biden has focused on lowering healthcare costs as part of his reelection campaign in November.
The piece in USA Today comes days after Biden's weak performance during a televised presidential debate with Republican Donald Trump sparked sharp concern among Democrats.
E.AbuRizq--SF-PST